Acasti Pharma Inc.
13F holders, Q2 2024 (June 30)12holders +2
3new positions
1sold out
$2.93avg. 13F price*
At the end of Q2 2024, 12 institutions reported holding Acasti Pharma Inc. in their 13F filings, up 2 from Q1 2024. 3 opened new positions and 1 sold out. The largest holders were ADAR1 Capital Management, LLC ($2.8M), AIGH Capital Management LLC ($1.9M) and Bank of America Corp. ($1.4M).
- Company
- Acasti Pharma Inc.
- CUSIP
- 00430K865
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $328 |
| Exits | 1 | $1K |
All 13F filers, Q1 2024 → Q2 2024: 892,957 shares bought and 6,002 shares sold, net +886,955 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| ADAR1 Capital Management, LLC | 0.56% | Add +341.4% | 959,571 | $2.8M |
| AIGH Capital Management LLC | 0.92% | Add +28.9% | 641,083 | $1.9M |
| Bank of America Corp. | 0.00% | No change | 494,698 | $1.4M |
| Susquehanna International Group, LLP | 0.00% | Add +3.1% | 37,793 | $113K |
| UBS Group AG | 0.00% | Add +297.3% | 7,735 | $23K |
| Royal Bank of Canada | 0.00% | Reduce -47.7% | 6,584 | $20K |
| National Bank of Canada | 0.00% | No change | 2,901 | $8K |
| Morgan Stanley | 0.00% | No change | 1,882 | $5K |
| Activest Wealth Management | 0.00% | New | 104 | $304 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 28 | $82 |
| IFP Advisors, Inc | 0.00% | New | 6 | $18 |
| JPMorgan Chase & Co. | 0.00% | New | 2 | $6 |
"% of holder's portfolio" is ACASTI PHARMA INC's weight in each manager's 13F, not the share of Acasti Pharma Inc. the manager owns.